DGAP-News: Epigenomics AG / Key word(s): Study results/Conference 2015-11-09 / 08:30 Press release Epigenomics AG: Novel panel of blood-based DNA methylation biomarkers shows promising results in the detection of lung cancer Epigenomics’ DNA methylation biomarkers demonstrate high sensitivity compared to commonly used protein biomarkers Being developed as a blood-based test for early lung cancer detection […]
Category: Press Releases
09. November 2015
Epigenomics AG: Novel panel of blood-based DNA methylation biomarkers shows promising results in the detection of lung cancer
Read more
04. November 2015
Epigenomics AG: FDA requests further data for approval of Epigenomics’ blood based colorectal cancer screening test
DGAP-News: Epigenomics AG / Key word(s): Regulatory Admission 2015-11-04 / 20:30 Press release FDA requests further data for approval of Epigenomics’ blood based colorectal cancer screening test FDA provides recommendations for amending the application in order to make it approvable Further study on increased compliance and adherence of Epi proColon(R) expected Strategic commercialization partner Polymedco […]
02. November 2015
Epigenomics AG: Epigenomics AG to provide an update on blood-based epigenetic tests at the Association of Molecular Pathology (AMP) 2015 Annual Meeting
DGAP-News: Epigenomics AG / Key word(s): Conference 2015-11-02 / 14:00 Press release Epigenomics AG to provide an update on blood-based epigenetic tests at the Association of Molecular Pathology (AMP) 2015 Annual Meeting Berlin (Germany) and Germantown, MD (U.S.A.), November 2, 2015 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), the German-American cancer molecular diagnostics […]
06. August 2015
Epigenomics AG: Epigenomics AG Announces Q2 2015 and 6M 2015 Financial Results and Reports on Operational Highlights
Epigenomics AG / Key word(s): Half Year Results 2015-08-06 / 08:30 Press release Epigenomics AG Announces Q2 2015 and 6M 2015 Financial Results and Reports on Operational Highlights Q2 2015 revenue increased by 20%, mainly driven by an increase in product sales of 36% European Commission granted up to EUR 2.8 million to Epigenomics for […]
15. July 2015
Epigenomics AG: Epigenomics and BioChain Announce the Inclusion of their Proprietary Blood-based Septin9 Test in the Chinese Screening Guideline for Colorectal Cancer
Epigenomics AG / Key word(s): Miscellaneous 2015-07-15 / 12:00 Press release Epigenomics and BioChain Announce the Inclusion of their Proprietary Blood-based Septin9 Test in the Chinese Screening Guideline for Colorectal Cancer Berlin (Germany), Germantown, MD, and Newark, CA (U.S.A.), Beijing (China), July 15, 2015 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), the German-American […]
28. May 2015
Epigenomics AG: Epigenomics AG Successfully Completes Capital Increase
Epigenomics AG / Key word(s): Capital Increase 2015-05-28 / 11:25 Press release Epigenomics AG Successfully Completes Capital Increase Total gross proceeds of EUR 4.9 million raised in a rights issue Transaction significantly over-subscribed Use of proceeds to finance market introductory measures for Epi proColon(R) in the U.S. Not for distribution in the United States Berlin […]